Characterization of polyamine biosynthetic enzymes from human gut microbes associated with colon and pancreatic cancer
Characterization of polyamine biosynthetic enzymes from human gut microbes associated with colon and pancreatic cancer
批准号:
10664019
负责人:
Jeffrey S McFarlane
金额:
$16.25万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-07-15 至 2026-06-30
关键词:
Adenosylmethionine DecarboxylaseAminesAnabolismAspartateBacterial Gene Expression RegulationBacteroidesBacteroides fragilisBiological AssayBiological ProcessCampylobacterCarbon DioxideCarboxy-LyasesCell ProliferationCellsClinical TrialsClostridiumColon CarcinomaDNA RepairDataDecarboxylationDevelopmentDiseaseDrug DesignDrug TargetingEnzyme KineticsEnzymesFutureGenesGoalsHumanKineticsLifeLinkMalignant NeoplasmsMalignant neoplasm of pancreasMetabolic PathwayMicrobial BiofilmsMinorNADPNADPH DehydrogenaseOperonOrganismOrthologous GeneOxidoreductasePathway interactionsPatientsPhysical condensationPolyaminesProcessProductionPublic HealthPutrescineRoleS-AdenosylhomocysteineSpermidineSpermidine SynthaseStructural ModelsStructureVariantVibrioWorkX-Ray Crystallographyanti-cancer therapeuticaspartic semialdehydecancer cellcolon cancer progressioncolorectal cancer treatmentcommensal bacteriadesignenzyme pathwayenzyme structuregut bacteriagut microbesgut microbiomeinhibitorkinetic modelmembernew therapeutic targetnorspermidineprogramstherapeutic targettumorigenesisuptake
中文摘要
项目总结
人类癌细胞中的多胺生物合成是一个长期的治疗靶点。积累证据
提示肠道微生物产生的多胺对结肠和胰腺的进展有贡献。
癌症。肠道细菌生物合成多胺亚精胺的途径与人类不同
途径使这一细菌途径成为独特的药物靶点。这一途径中的两个中心酶,
羧基亚精胺脱氢酶和羧基亚精胺脱氢酶仅得到有限的
人物刻画。我们建议解决一个羧基亚精胺脱氢酶的第一个结构,并
描述羧基亚精胺脱氢酶功能的发展动力学和结构模型
类杆菌属和梭状芽孢杆菌属的主要肠道成分中的羧亚精胺脱羧酶。
这些目标是未来机制导向药物设计计划的必要先导。长的-
这项工作的长期目标是为结直肠癌和胰腺癌的治疗开辟新的途径。有趣的是,
来自许多肠道属的预测的多胺生物合成酶的基因似乎编码冗余。
生产亚精胺的途径。我们假设这些路径不是冗余的,而是生成
独特的多胺产品。我们建议使用LC-TQ-MS分析方法来描述从
显然在梭状芽胞杆菌中发现了多余的酶对。亚精胺合成酶是这一目标的一个关键焦点,因为
这种酶的原核同源物已被证明除了产生多种多胺产物外,还能产生多种多胺产品。
亚精胺。这项工作将扩大我们对键中发现的功能变化的基本理解
肠道微生物代谢途径:多胺生物合成。
英文摘要
PROJECT SUMMARY
Polyamine biosynthesis in human cancer cells is a long-standing therapeutic target. Accumulating evidence
suggests that polyamine production by gut microbes contributes to the progression of colon and pancreatic
cancer. Biosynthesis of the polyamine spermidine by gut bacteria follows a pathway distinct from the human
pathway making this bacterial pathway a unique drug target. The two central enzymes in this pathway,
carboxyspermidine dehydrogenase and carboxyspermidine decarboxylase, have received only limited
characterization. We propose to solve the first structure of a carboxyspermidine dehydrogenase and to
development kinetic and structural models describing the function of both carboxyspermidine dehydrogenase
and carboxyspermidine decarboxylase in major gut constituents from the Bacteroides and Clostridium genera.
These aims serve as a necessary precursor to a future program of mechanism-guided drug design. The long-
term goal of this work is to open new avenues for the treatment of colorectal and pancreatic cancer. Interestingly,
the genes of predicted polyamine biosynthetic enzymes from many gut genera appear to encode redundant
paths toward the production of spermidine. We hypothesize that these paths are not redundant, but generate
unique polyamine products. We propose the use of LC-TQ-MS assays to delineate the polyamine products from
apparently redundant enzyme pairs found in Clostridium. Spermidine synthase is a key focus of this aim because
the prokaryotic orthologs of this enzyme have been shown to produce a variety of polyamine products besides
spermidine. This work will expand our fundamental understanding of the functional variations found within a key
gut microbe metabolic pathway: polyamine biosynthesis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Stopped-flow spectrometer for analysis of reaction kinetics
-
批准号:10796272
-
项目类别:
-
资助金额:$9.45万
-
财政年份:2022
-
负责人:Jeffrey S McFarlane
-
依托单位:
海外基金